...
首页> 外文期刊>Journal of Periodontology >Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial.
【24h】

Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial.

机译:单独使用富含血小板的血浆或与脱矿质的冻干同种异体骨联合治疗牙周骨内缺损:一项比较性临床试验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Platelet-rich plasma (PRP) alone or combined with other regenerative materials was previously studied in human periodontal endosseous defects. There are no sufficient data evaluating to what extent the addition of demineralized freeze-dried bone allograft (DFDBA) to PRP may enhance the effectiveness of PRP. The aim of this randomized, double-masked, controlled clinical trial was to compare the effectiveness of autologous PRP alone to PRP + DFDBA in periodontal endosseous defects. METHODS: Twenty-four proximal endosseous defects in 24 patients with severe chronic periodontitis were randomly treated with PRP alone or in combination with DFDBA. The final evaluation at 6 months was based on clinical and radiographic parameters. Subtraction radiography was used. The primary outcome variable was clinical attachment level (CAL). RESULTS: The two treatment groups were initially comparable (mean CAL: 8.67 +/- 2.19 mm for PRP + DFDBA and 8.25 +/- 1.96 mm for PRP). Both treatments achieved statistically significant and similar CAL gain (3.08 +/- 1.17 mm for PRP + DFDBA and 3.08 +/- 0.95 mm for PRP), probing depth, defect depth, and area surface reduction. The percentage of defect fill did not significantly differ between the two treatments. There was a non-significant trend to greater defect fill (45.42% versus 41.29%), defect depth (54.05% versus 49.52%), and area surface (58.43% versus 52.16%) reduction with the graft. In both groups, 66.66% of the defects gained > or =3 mm of CAL. CONCLUSION: Within its limits, this study demonstrates that both PRP and PRP combined with DFDBA resulted in significant clinical and radiographic improvement in human periodontal endosseous defects at 6 months, and the addition of DFDBA to PRP did not significantly enhance the treatment outcome.
机译:背景:以前曾在人类牙周骨内缺损中研究了单独或与其他再生材料结合的富血小板血浆(PRP)。没有足够的数据评估在PRP中添加脱矿质冻干同种异体骨(DFDBA)可以在多大程度上增强PRP的有效性。这项随机,双掩蔽,对照临床试验的目的是比较自体PRP与PRP + DFDBA在牙周骨内缺损中的有效性。方法:对24例重度慢性牙周炎患者的24个近端骨内缺损进行随机PRP单独治疗或与DFDBA联合治疗。在6个月时的最终评估基于临床和放射学参数。使用减法射线照相。主要结果变量是临床依从水平(CAL)。结果:两个治疗组最初具有可比性(平均CAL:PRP + DFDBA为8.67 +/- 2.19 mm,PRP为8.25 +/- 1.96 mm)。两种处理均实现了统计学上显着且相似的CAL增益(PRP + DFDBA为3.08 +/- 1.17 mm,PRP为3.08 +/- 0.95 mm),探测深度,缺陷深度和面积减少。两种处理之间的缺陷填充百分比没有显着差异。移植物的缺损填充率(45.42%vs 41.29%),缺损深度(54.05%vs 49.52%)和面积表面积(58.43%vs 52.16%)减少的趋势不明显。在两组中,有66.66%的缺陷获得CAL≥3 mm。结论:在其极限范围内,这项研究表明PRP和PRP联合DFDBA可以在6个月时显着改善人牙周骨内膜缺陷的临床和影像学改善,并且在PRP中添加DFDBA并不能显着提高治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号